|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-4.27/3.14
|
Enterprise Value
3.01M
|
Balance Sheet |
Book Value Per Share
1.02
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
787.00K
|
Operating Revenue Per Share
0.23
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/01/21 05:31 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. |